In Vitro Biology Services

In Vitro Biology Services for Oncology and Immunology Research

Kyinno Bio provides a comprehensive range of in vitro services designed to accelerate discovery in oncology and immunology. Our cell-based functional assays and biochemical assays enable precise evaluation of cell behavior, drug responses, and immune interactions, offering critical insights for tumor models, therapeutic antibody testing, and early-stage target identification. These studies support downstream target validation, phenotypic analysis, and cell cycle analysis, helping researchers better understand protein-protein interactions and target engagement. From early-stage high-throughput screening to detailed mechanism-of-action studies, our oncology assay services guide decision-making before moving to in vivo models. With expertise across multiple assay formats, we combine advanced in vitro imaging-based assays, Digital PCR, and mass spectrometry for precise quantification and molecular profiling. By integrating recombinant proteins and immune-based functional platforms, we deliver high-quality, reproducible results tailored to diverse research objectives.

Comprehensive In Vitro Biology Assay Portfolio

Our assay portfolio covers key areas of cellular and molecular research, including:

  • Proliferation assays for tumor growth dynamics.
  • Immune cell assays, Cytotoxicity assays and immune-mediated killing assessments such as ADCC and ADCP .
  • Immune response profiling using immuno-oncology assays and ELISA-based biomarker quantification.
  • Internalization assays to monitor therapeutic antibody uptake.
  • 3D organoid models for physiologically relevant drug testing.
  • Cellular movement tracking to evaluate migration and invasion potential.

Kyinno supports both high-throughput studies and specialized, custom-designed experiments. Our in vitro workflows can be seamlessly integrated with in vivo models and recombinant production antibody services, enabling an end-to-end research solution. Whether you are validating a lead candidate or exploring novel mechanisms, our platforms are optimized for translational relevance.

Why Choose Kyinno Bio for In Vitro Biology Services?

  • Access to a wide variety of validated tumor models and screening platforms.
  • Fully customizable experimental designs to align with specific assay development needs.
  • Integration with in vivo models, target identification programs, and antibody production pipelines.
  • Expert support in assay planning, execution, and data interpretation, including advanced phenotypic analysis and cell line engineering.

Our team is committed to delivering scientifically rigorous data that informs decision-making and accelerates therapeutic development.

Get Started with In Vitro Studies at Kyinno Bio

At Kyinno Bio, we deliver precision-driven in vitro studies that leverage assay development, in vitro imaging-based assays, enzyme screening, and cell-based assays to meet the exact requirements of your research. Whether your focus is small molecules, biologics, or integrated Discovery Biology workflows, our scientists oversee every stage—from concept and target validation to advanced data interpretation—ensuring outcomes with strong translational value.

Reach out today to discuss your project needs.

All In Vitro Services

2D Cell Proliferation Assay

The 2D Cell Proliferation Assay, a primary method for cell growth studies, focuses on tumor cells cultured in suspension or monolayers. It allows for comprehensive analysis, highlighting cell development dynamics.

The utility of tumor cell lines as research models and drug discovery tools is significantly enhanced by understanding the genetic abnormalities driving their phenotypes. Kyinno’s MegaScreen cell panel screening service provide tailored studies for drug discovery and biomarker development programs.
Organoids, sophisticated 3D organ replicas grown in vitro, are vital in biomedical research, aiding disease modeling, drug testing, and understanding organ development. KYinno excels in cultivating organoids from diverse tumor tissues, collaborating closely with cancer hospitals to ensure translational relevance.

Internalization Assay evaluates cellular absorption rates of monoclonal antibodies, vital for advancing anti-cancer and anti-inflammatory therapies. This process is essential for developing anti-cancer and anti-inflammatory treatments and refining oncology and inflammation treatments.

An ELISA assay is an indispensable technique that stands out for its high sensitivity and specificity in antigen-antibody binding interactions. Its precision ensures it remains the preferred choice for many immune response studies.
A FACS Binding Assay or Fluorescence-Activated Cell Sorting is a pivotal cellular biology research technique for binding evaluation. It offers insights into cellular binding mechanisms, enriching our understanding of cell interactions.
Immuno-Oncology Assay is a core tool in tumor immunology, providing detailed information designed to analyze interactions between tumors and immune responses.This deep understanding accelerates advancements in tumor immunology research.
ADCC Assay measures antibody efficacy in biological research. A standard method for understanding antibody performance. It rigorously tests their functionality and efficacy, providing insights into antibody-mediated cell destruction processes.